- Home
- BB vs LGND Comparison
BB vs LGND Comparison
Compare BB & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BB
- LGND
- Stock Information
- Founded
- BB 1984
- LGND 1987
- Country
- BB Canada
- LGND United States
- Employees
- BB N/A
- LGND 68
- Industry
- BB
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- BB
- LGND Health Care
- Exchange
- BB Nasdaq
- LGND Nasdaq
- Market Cap
- BB 2.2B
- LGND 2.2B
- IPO Year
- BB 1997
- LGND 1992
- Fundamental
- Price
- BB $3.86
- LGND $161.71
- Analyst Decision
- BB Buy
- LGND Strong Buy
- Analyst Count
- BB 6
- LGND 8
- Target Price
- BB $4.64
- LGND $144.71
- AVG Volume (30 Days)
- BB 7.1M
- LGND 139.7K
- Earning Date
- BB 09-25-2025
- LGND 08-05-2025
- Dividend Yield
- BB N/A
- LGND N/A
- EPS Growth
- BB N/A
- LGND N/A
- EPS
- BB N/A
- LGND N/A
- Revenue
- BB $533,200,000.00
- LGND $181,488,000.00
- Revenue This Year
- BB $2.17
- LGND $18.41
- Revenue Next Year
- BB $7.03
- LGND $18.87
- P/E Ratio
- BB N/A
- LGND N/A
- Revenue Growth
- BB 4.65
- LGND 53.40
- 52 Week Low
- BB $2.22
- LGND $81.74
- 52 Week High
- BB $6.24
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- BB 51.58
- LGND 72.86
- Support Level
- BB $3.78
- LGND $158.40
- Resistance Level
- BB $3.93
- LGND $161.89
- Average True Range (ATR)
- BB 0.10
- LGND 4.02
- MACD
- BB 0.03
- LGND -0.12
- Stochastic Oscillator
- BB 68.95
- LGND 88.63
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.